Qasim Ahmad
Vermogen: 191 $ op 30-06-2026
Vermogen: 191 $ op 30-06-2026
Qasim Ahmad worked at IO Biotech, Inc. as Chief Medical Officer.
Dr. Ahmad worked at Novartis AG as SVP, Head-Clinical Development & Medical Affairs.
Dr. Ahmad graduated from the University of Birmingham, London School of Hygiene & Tropical Medicine, and the University of Surrey.
Dr. Ahmad earned a doctorate from Panjab University Chandigarh.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IO BIOTECH, INC. 0,04% | 11-04-2025 | 31.350 ( 0,04% ) | 191 $ | 30-06-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IO BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | 15-02-2026 |
| NOVARTIS AG | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 6 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panjab University Chandigarh
Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IO Biotech, Inc.
IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau